Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2013; 19(48): 9282-9293
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9282
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9282
Univariate | Multivariate | ||||||
HR | 95%CI | Pvalue | HR | 95%CI | Pvalue | ||
Patient factors | |||||||
Age | 0.972 | (0.944-1.00) | 0.054 | ||||
Sex | Female | 1.000 | Ref | ||||
Male | 0.953 | (0.453-2.005) | 0.899 | ||||
ASA | 1 | 1.000 | Ref | ||||
2 | 0.696 | (0.313-1.548) | 0.374 | ||||
3 | 0.947 | (0.352-2.546) | 0.914 | ||||
Performance status | 0 | 1.000 | Ref | ||||
1 | 1.016 | (0.578-1.789) | 0.955 | ||||
2 | 0.950 | (0.218-4.129) | 0.945 | ||||
O-POSSUM | |||||||
Tumour response | |||||||
TRG | 1 | 1.000 | Ref | ||||
2 | 1.099 | (0.099-12.148) | 0.939 | ||||
3 | 8.404 | (1.071-65.929) | 0.043 | ||||
4 | 7.829 | (1.054-58.163) | 0.044 | ||||
5 | 15.422 | (2.083-114.189) | 0.007 | ||||
TRG grouped | 1-2 | 1.000 | Ref | 1.000 | Ref | ||
3-5 | 9.504 | (2.973-30.380) | < 0.0001 | 6.315 | (1.261-31.616) | 0.025 | |
Lymph node response | |||||||
Lymph nodes downstaged | Yes | 1.000 | Ref | 1.000 | Ref | ||
No | 5.784 | (3.064-10.919) | < 0.0001 | 6.161 | (1.683-22.554) | 0.006 | |
Tumour factors | |||||||
ypT stage | 0 | 1.000 | Ref | 1.000 | Ref | ||
1 | 2.085 | (0.232-18.711) | 0.512 | 0.281 | (0.020-3.928) | 0.345 | |
2 | 5.214 | (0.687-39.549) | 0.110 | 0.286 | (0.022-3.705) | 0.338 | |
3 | 9.490 | (1.293-69.635) | 0.027 | 0.469 | (0.034-6.460) | 0.571 | |
4 | 52.907 | (6.008-465.873) | < 0.0001 | 1.519 | (0.087-26.389) | 0.774 | |
ypN stage | 0 | 1.000 | Ref | 1.000 | Ref | ||
1 | 4.791 | (2.434-9.431) | < 0.0001 | 0.476 | (0.133-1.700) | 0.253 | |
2 | 4.102 | (2.005-8.392) | < 0.0001 | 0.254 | 0.070-0.927) | 0.038 | |
3 | 7.449 | (3.522-15.756) | < 0.0001 | 0.476 | (0.129-1.755) | 0.265 | |
ypM stage | 0 | 1.000 | Ref | 1.000 | Ref | ||
1 | 3.172 | (1.253-8.031) | 0.015 | 2.693 | (0.924-7.847) | 0.069 | |
Vascular invasion | No | 1.000 | Ref | 1.000 | Ref | ||
Yes | 3.444 | (2.080-5.702) | < 0.0001 | 1.929 | (1.034-3.600) | 0.039 | |
Lymphatic invasion | No | 1.000 | Ref | 1.000 | Ref | ||
Yes | 2.201 | (1.268-3.821) | 0.005 | 1.253 | (0.637-2.462) | 0.514 | |
Perineural invasion | No | 1.000 | Ref | 1.000 | Ref | ||
Yes | 5.073 | (2.896-8.886) | < 0.0001 | 2.766 | (1.444-5.300) | 0.002 | |
Resection clearance | R0 | 1.000 | Ref | 1.000 | Ref | ||
R1 | 3.869 | (2.272-6.588) | < 0.0001 | 1.805 | (0.940-3.468) | 0.076 |
- Citation: Noble F, Nolan L, Bateman AC, Byrne JP, Kelly JJ, Bailey IS, Sharland DM, Rees CN, Iveson TJ, Underwood TJ, Bateman AR. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus. World J Gastroenterol 2013; 19(48): 9282-9293
- URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9282.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9282